Cystic Fibrosis (CF) Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Cystic Fibrosis (CF) Diagnostics Market By Test Type (Antenatal testing, Carrier testing, Sweat tests, CFTR-Related Metabolic Syndrome (CRMS), Newborn screening, Prenatal screening), by Product Type (Diagnostic Kits, Reagents, and Others) End User (Hospitals and Diagnostic Centers) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Cystic Fibrosis (CF) Diagnostics Market Outline

Cystic fibrosis (CF) is a chronic, genetic disease that causes persistent lung infections and limits the ability to breathe over time. Several mutations in the gene is responsible for Cystic fibrosis that encodes cystic fibrosis transmembrane conductance regulator (CFTR) protein. Patients with CF have inherited two copies of the defective CF gene — one copy from each parent. Both parents must have at least one copy of the defective gene. Currently there are approximately 70,000 people who are suffering from cystic fibrosis worldwide, according to the Cystic Fibrosis Foundation (CFF). Some of the popular methods of diagnosis are antenatal testing, carrier testing, and other tests such as genetic tests and sweat tests According to Cystic Fibrosis Foundation, the incidence of these hereditary disorders is constantly growing. The nonprofit organizations are investing huge amount of funds to find various therapeutics for CF and to support the research & developmental activities. In February 2018, Luminex’s xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM in Brazil. Cystic Fibrosis (CF) Diagnostics Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on gives historical, current, and future market sizes (US$ Mn) on the basis of product type, test type end-user, and region. This report studies global Cystic Fibrosis (CF) Diagnostics Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged

Cystic Fibrosis (CF) Diagnostics Market

MARKET SUMMARY
-
x
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– X%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Cystic Fibrosis (CF) Diagnostics Market Analysis

  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global Cystic Fibrosis (CF) Diagnostics market
  • In March 2017, Elucigene Diagnostics announced the official launch of new CF-Italia kit (CF1ITB1).
  • In April 2017, Elucigene Diagnostics partnered with Southern Cross Diagnostics in order to expand in Australia and New Zealand markets
Market Leaders
  • Elucigene
  • Asper Biogene
  • ELITechGroup
  • Natera, Inc.
  • Randox Laboratories Ltd.
  • Luminex Corporation
  • Appolon Bioteck
  • Arazy Group
  • Illumina Inc.
Cystic Fibrosis (CF) Diagnostics Market

Drivers and Restraints

The major driver for the market is improved diagnostic technologies. Increase in investment and awareness about genetic diseases are aiding in development of diagnostic technologies, which will fuel the market growth. The high cost of the drugs and treatment may hamper the growth of the market. The global cystic fibrosis diagnostics market is expected to witness tremendous growth. Novel diagnostic tools for cystic fibrosis are being developed. The scientists at Stanford University, have developed a DNA test for the accurate and comprehensive screening of newborns for cystic fibrosis. By this test the next-generation DNA sequencing can be identified and this test is considered to be less expensive and less time-consuming technology.


Cystic Fibrosis (CF) Diagnostics Market Regional Analysis

North America dominates the market

Geographically, global Cystic Fibrosis (CF) Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The higher incidence rate of cystic fibrosis is observed in North America. The median age of the person with cystic fibrosis is currently 33.4 years according cystic fibrosis foundation’s national patient registry. Followed by North America is the European region which has more affected population with cystic fibrosis. Out of this affected population, 51.8% were adults and 48.2% were less than 18 years old. Whereas the birth prevalence of CF is higher in United Kingdom, Ireland, Romania, and Bulgaria. When it comes to the Asian region, the prevalence of cystic fibrosis is seen to be very low. The Middle East and Africa holds the lowest share in the market, especially countries in the African region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Cystic Fibrosis (CF) Diagnostics Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

  1. Executive Summary
  2. Global Cystic Fibrosis (CF) Diagnostics Market Introduction
    • Global Cystic Fibrosis (CF) Diagnostics Market – Taxonomy
    • Global Cystic Fibrosis (CF) Diagnostics Market –Definitions
      • Test Type
      • Product Type
      • End User
  1. Global Cystic Fibrosis (CF) Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Cystic Fibrosis (CF) Diagnostics Market Dynamic Factors – Impact Analysis
    • Global Cystic Fibrosis (CF) Diagnostics Market – Competition Landscape
    • Epidemiology
  2. Global Cystic Fibrosis (CF) Diagnostics Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Cystic Fibrosis (CF) Diagnostics Market, By Test Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Antenatal Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Carrier Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Sweat Tests
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CFTR-Related Metabolic Syndrome (CRMS)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Newborn Screening
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prenatal Screening
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026
    • Diagnostic Kits
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Reagents
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospital
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic centers
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Region, 2020 – 2026
  2. North America Cystic Fibrosis (CF) Diagnostics MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
    • North America Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  3. Europe Cystic Fibrosis (CF) Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
    • Europe Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  4. Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
    • Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  5. Latin America Cystic Fibrosis (CF) Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
    • Latin America Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  6. Middle East and Africa Cystic Fibrosis (CF) Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
    • MEA Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Test Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Elucigene
      • Asper Biogene
      • ELITechGroup
      • Natera, Inc.
      • Randox Laboratories Ltd.
      • Luminex Corporation
      • Appolon Bioteck
      • Arazy Group
      • Illumina Inc.
  1. Research Methodology
  2. Key Assumptions and Acronyms

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.


Report

Company Profile

  • Elucigene
  • Asper Biogene
  • ELITechGroup
  • Natera, Inc.
  • Randox Laboratories Ltd.
  • Luminex Corporation
  • Appolon Bioteck
  • Arazy Group
  • Illumina Inc.

Description

Cystic Fibrosis (CF) Diagnostics Market Outline

Cystic fibrosis (CF) is a chronic, genetic disease that causes persistent lung infections and limits the ability to breathe over time. Several mutations in the gene is responsible for Cystic fibrosis that encodes cystic fibrosis transmembrane conductance regulator (CFTR) protein. Patients with CF have inherited two copies of the defective CF gene — one copy from each parent. Both parents must have at least one copy of the defective gene. Currently there are approximately 70,000 people who are suffering from cystic fibrosis worldwide, according to the Cystic Fibrosis Foundation (CFF). Some of the popular methods of diagnosis are antenatal testing, carrier testing, and other tests such as genetic tests and sweat tests According to Cystic Fibrosis Foundation, the incidence of these hereditary disorders is constantly growing. The nonprofit organizations are investing huge amount of funds to find various therapeutics for CF and to support the research & developmental activities. In February 2018, Luminex’s xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM in Brazil. Cystic Fibrosis (CF) Diagnostics Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on gives historical, current, and future market sizes (US$ Mn) on the basis of product type, test type end-user, and region. This report studies global Cystic Fibrosis (CF) Diagnostics Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX